Romark Alinia Cryptosporidium Indication Expanded To Adults, Teens
This article was originally published in The Pink Sheet Daily
Executive Summary
Supplement receives priority review at FDA; previous indication was in children ages one to 11 years. The firm is looking at future indications in Crohn’s disease and Clostridium difficile-associated diarrhea.
You may also be interested in...
Velcade Double Entendre Raises Red Flags At FDA Over Reminder Ads
Agency cites Millennium and Romark for misleading promotions.
Spectrum’s Iso-Vorin Could Clear FDA For Osteosarcoma By First Quarter
The Irvine, Calif., firm also plans sNDAs for a colorectal cancer claim and an oral formulation of the leucovorin relative.